Endovenous ablation devices are used to treat chronic venous insufficiency (CVI) with varicose veins. These type of devices are specially designed for minimally invasive procedures. Symptoms of varicose veins disease include large, swollen veins that often appear on legs and feet. This is happened when veins do not work properly, resulted blood does not flow effectively. In severe cases, varicose veins may rupture, or develop into varicose ulcers on the skin.

There are three type of endovenous ablation devices available in the market: endovenous laser ablation therapy (EVLT) devices, radiofrequency ablation (RFA) devices, and non-thermal non-tumescent (NTNT) devices. Endovenous laser ablation therapy is a method of treating varicose veins without surgery, in which, veins are heated by a laser. Radiofrequency ablation involves using an electrical current produced by a radio wave to heat up the nerve tissues in the affected area of a vein, thereby reducing the pain in that area.

To Know More about TMRs Unique Offerings for Endovenous Ablation Devices Market, Request a Brochure here

Global Endovenous Ablation Devices Market: Competitive Landscape

Major players have adopted strategies such as partnerships, agreements, new product development, and collaborations to gain competitive advantage in the global endovenous ablation devices market.

  • In January 2019, Medtronic Plc acquired EPIX Therapeutics for expanding its ablation product portfolio
  • In January 2019, Venclose, Inc. partnered with Viant to deliver next-generation vein treatment solutions

Teleflex Incorporated

  • Founded in 1943, Teleflex Corporation is based in Wayne, New Jersey, U.S. The company has a diverse product portfolio with solutions in fields such as interventional access, vascular access, cardiology, anesthesia, surgical care, respiratory care, and emergency services. It provides Endovenous Ablation Procedure Packs for both endovenous laser ablation and radiofrequency ablation procedures.

 Medtronic Plc

  • Established in 1949, Medtronic is based in Minneapolis, Minnesota, U.S. The company operates through four main business segments: Cardiac & Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. Medtronic operates in 160 countries across 480 locations globally, serving more than 65 million patients. It holds more than 45,000 patents in the medical technology industry. Medtronic offers products including Evident MW Ablation System, Cool-tip RF Ablation System, and Emprint SX Ablation Platform with Thermosphere Technology.

AngioDynamics

  • Founded in 1888, AngioDynamics is a minimally invasive medical devices provider for oncology, peripheral vascular disease, surgery, ablation, dialysis, and vascular access. The company has more than 1200 employees and it distributes its products in more than 50 countries across Europe, the U.S., Asia, and Latin America. The company has broad product portfolio that includes Solero Microwave Tissue Ablation System, NanoKnife System, StarBurst Radiofrequency Ablation System, and StarBurst MRI RFA Device for treatment of varicose veins.

 Venclose, Inc.

  • Founded in 2014, Venclose, Inc. is a medical technology company engaged in developing next-generation solutions for treatment of chronic venous insufficiency. Venclose, Inc. provides a wide range of products for the treatment of chronic venous insufficiency, such as Venclose System, VENCLOSE RF Ablation Catheter, and VENCLOSE RF Generator.

Looking for Customized Insights to build your Business for Future, Ask for a Custom Report here

Global Endovenous Ablation Devices Market: Dynamics

Increase in Prevalence of Chronic Venous Insufficiency and Associated Risk Factors to Boost Market

Increase in prevalence of chronic venous insufficiency is a major factor for expansion of the endovenous ablation devices market. According to a recent study, around 10% of adults suffer from chronic venous insufficiency. The prevalence of chronic venous insufficiency disease is high in developed countries as compared to developing countries. Untreated chronic venous insufficiency disease becomes life threatening. In addition, increasing prevalence of obesity, aging, smoking, and lack of physical activities are likely to cause chronic venous insufficiency disease. All these factors are expected to boost the market.

Focus on Launch of Innovative Products to Boost Endovenous Ablation Devices Market

Manufacturers operating in the endovenous ablation devices market are strongly focusing on increasing investments in the research & development activities to design and develop new and innovative endovenous ablation devices. For instance, Medtronic plc has developed an innovative product, VenaSeal Closure System, which is the only non-thermal, non-tumescent, and non-sclerosant procedure that uses a proprietary medical adhesive delivered endovenously to close the vein.

Global Endovenous Ablation Devices Market: Segmentation

Based on technology, the global endovenous ablation devices market can be divided into:

  • Endovenous Laser Ablation Therapy (EVLT) Devices
  • Radiofrequency Ablation (RFA) Devices
  • Non-thermal Non-tumescent (NTNT) Devices

In terms of end-user, the global endovenous ablation devices market can be classified into:

  • Hospitals
  • Clinics
  • Others

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.